华泰联合证券有限责任公司 关于深圳市德方纳米科技股份有限公司 2023 年度向不特定对象发行可转换公司 债券并在创业板上市之 发行保荐书 保荐人（主承销商） （深圳市前海深港合作区南山街道桂湾五路128号前海深港基金小镇B7栋401） 发行保荐书 华泰联合证券有限责任公司 关于深圳市德方纳米科技股份有限公司 2023 年度向不特定对象发行可转换公司债券 并在创业板上市之发行保荐书 深圳市德方纳米科技股份有限公司（以下简称"发行人"、"公司"、"德方纳 米"）申请向不特定对象发行可转换公司债券并在创业板上市，依据《公司法》 《证券法》《上市公司证券发行注册管理办法》（以下简称"《再融资注册办法》"） 等相关的法律、法规的有关规定，提交发行申请文件。华泰联合证券有限责任公 司（以下简称"华泰联合证券"、"保荐人"）作为其本次发行的保荐人，肖耿豪和 董瑞超作为具体负责推荐的保荐代表人，特为其出具本发行保荐书。 保荐人华泰联合证券、保荐代表人肖耿豪和董瑞超承诺：本保荐人和保荐代 表人根据《公司法》《证券法》等有关法律、法规和中国证监会、深圳证券交易 所的有关规定，诚实守信、勤勉尽责，严格按照依法制定的业务规则、行业执 ...

上市保荐书 华泰联合证券有限责任公司关于 深圳市德方纳米科技股份有限公司 2023 年度向不特定对象 发行可转换公司债券并在创业板上市之上市保荐书 深圳证券交易所： 作为深圳市德方纳米科技股份有限公司（以下简称"发行人"、"公司"） 2023 年度向不特定对象发行可转换公司债券并在创业板上市的保荐人，华泰联 合证券有限责任公司及其保荐代表人已根据《中华人民共和国公司法》（以下简 称《公司法》）、《中华人民共和国证券法》（以下简称《证券法》）《上市公司证券 发行注册管理办法》（以下简称"《再融资注册办法》"）等法律法规和中国证 券监督管理委员会（以下简称中国证监会）及贵所的有关规定，诚实守信，勤勉 尽责，严格按照依法制定的业务规则和行业自律规范出具上市保荐书，并保证所 出具文件真实、准确、完整。 现将有关情况报告如下： 一、发行人基本情况 （一）发行人概况 发行人名称：深圳市德方纳米科技股份有限公司 注册地址：深圳市南山区桃源街道福光社区留仙大道 3370 号南山智园崇文 园区 1 号楼 1001 注册时间：2007 年 1 月 25 日 联系方式：86-0755-26918296 （二）发行人的主营业务 公司 ...

关于深圳市德方纳米科技股份有限公司 申请向不特定对象发行可转换公司债券 审核问询函的回复报告 （修订稿） 保荐人（主承销商） （深圳市前海深港合作区南山街道桂湾五路128号前海深港基金小镇B7栋401） 深圳市德方纳米科技股份有限公司 审核问询函的回复报告 深圳证券交易所： 贵所于 2023 年 5 月 10 日出具的《关于深圳市德方纳米科技股份有限公司申 请向不特定对象发行可转换公司债券的审核问询函》（审核函〔2023〕020079 号） （以下简称"审核问询函"）已收悉。深圳市德方纳米科技股份有限公司（以下 简称"公司"、"德方纳米"或"发行人"）与华泰联合证券有限责任公司（以下 简称"保荐人"）、北京市中伦律师事务所（以下简称"发行人律师"）、容诚会计 师事务所（特殊普通合伙）（以下简称"发行人会计师"）等相关方对审核问询函 所列问题进行了核查，对申请材料认真地进行了修改、补充和说明。现对问询函 的落实和募集说明书的修改情况逐条书面回复，并提交贵所，请予审核。 说明： 1、如无特殊说明，本回复报告中使用的简称或名词释义与《深圳市德方纳 米科技股份有限公司向不特定对象发行可转换公司债券并在创业板上市募集说 ...

证券代码：300769 证券简称：德方纳米 深圳市德方纳米科技股份有限公司 投资者关系活动记录表 编号：2023-005 □特定对象调研 □分析师会议 □媒体采访 □业绩说明会 投资者关系 □新闻发布会 □路演活动 活动类别 □现场参观 ■其他（电话会议） 中信证券、民生证券、中信建投证券、东吴证券、海通证券、国 泰君安证券、招商证券、国信证券、广发基金、中欧基金、工银 瑞信基金、易方达基金、嘉实基金、南方基金、博时基金、兴全 基金、汇添富基金、华安基金、银华基金、交银施罗德基金、平 参与单位名 安基金、国泰基金、建信基金、景顺长城基金、大成基金、朱雀 称及人员姓 基金、诺德基金、鹏华基金、海富通基金、申万菱信基金、万家 名 基金、高盛亚洲、贝莱德、Millennium、瓴仁投资、加拿大鲍尔公 司、Balyasny、建银国际、太平养老、长江养老、人保资产、清和 泉资本、淡水泉投资、太平洋保险资管等机构参与（以上排名不 分先后） 时间 2023 年 7 月 16 日-7 月 17 日 地点 电话会议 上市公司接 待人员姓名 董事会秘书何艳艳女士、财务总监林旭云女士、董事万远鑫先生 一、 公司 2023 年半年度 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥4,944,745,935.53, representing a 46.56% increase compared to ¥3,373,860,080.51 in the same period last year[4] - The net profit attributable to shareholders was -¥717,334,775.51, a decrease of 194.17% from ¥761,713,535.71 in the previous year[4] - The net cash flow from operating activities improved by 54.64%, amounting to -¥783,419,218.59, compared to -¥1,727,195,118.12 in the same period last year[4] - The weighted average return on equity was -8.46%, a significant decline from 21.64% in the same period last year[4] - The company reported a basic earnings per share of -¥4.14, a decrease of 187.34% from ¥4.74 in the previous year[4] - The total operating revenue for the first quarter of 2023 was CNY 4,944,745,935.53, an increase from CNY 3,373,860,080.51 in the same period last year, representing a growth of approximately 46.7%[56] - The total operating costs for the first quarter of 2023 were CNY 5,295,603,524.53, up from CNY 2,468,714,654.32 in the previous year, indicating an increase of about 114%[56] - The company's net profit for the first quarter was not explicitly stated, but the retained earnings decreased to CNY 2,721,020,915.40 from CNY 3,438,355,690.91, a decline of about 20.9%[56] - The net profit for the current period is -907,989,332.91 CNY, compared to a net profit of 775,868,515.18 CNY in the previous period, indicating a significant decline[57] - The total comprehensive income for the current period is -951,675,795.14 CNY, while it was 775,868,515.18 CNY in the previous period, reflecting a substantial decrease[58] - The operating profit for the current period is -1,055,902,238.41 CNY, compared to an operating profit of 906,760,302.45 CNY in the previous period[57] Assets and Liabilities - Total assets at the end of the reporting period were ¥27,106,275,767.79, down 6.83% from ¥29,094,244,309.19 at the end of the previous year[4] - The company’s total equity attributable to shareholders decreased by 7.60%, amounting to ¥8,143,100,322.98 compared to ¥8,813,064,394.06 at the end of the previous year[4] - The total liabilities decreased to CNY 17,253,884,018.08 from CNY 18,434,905,235.70, reflecting a reduction of approximately 6.4%[54] - The company's cash and cash equivalents decreased to CNY 2,825,008,779.66 from CNY 3,513,218,178.72, a decline of approximately 19.6%[51] - The company's total assets at the end of the period amount to 2,052,682,755.82 CNY, compared to 1,063,431,953.95 CNY at the end of the previous period[60] Cash Flow - Cash flow from operating activities shows a net outflow of -783,419,218.59 CNY, improving from -1,727,195,118.12 CNY in the previous period[59] - Cash flow from investing activities results in a net outflow of -730,915,260.27 CNY, compared to -1,157,843,201.63 CNY in the previous period[59] - Cash flow from financing activities shows a net inflow of 1,286,018,848.44 CNY, down from 2,685,485,440.52 CNY in the previous period[60] - The company reported a significant increase in cash received from sales, totaling 2,102,585,131.06 CNY, compared to 558,381,586.25 CNY in the previous period[58] Investments and Financing - The company signed an investment agreement for a new production base with an annual capacity of 110,000 tons of new phosphate-based cathode materials, with a total investment of approximately CNY 2.5 billion[27] - The company plans to raise up to CNY 3.5 billion through a convertible bond issuance to fund the new production base and supplement working capital[28] - Long-term borrowings increased by 76.39% to CNY 4,370,786,030.72, primarily due to increased bank financing during the reporting period[17] - The company issued convertible bonds to unspecified investors, although details regarding the amount and terms were not disclosed in the report[49] Accounts Receivable and Inventory - Accounts receivable decreased by 39.87% to CNY 2,625,490,208.92 due to the collection of overdue payments during the reporting period[17] - Inventory decreased by 51.43% to CNY 2,493,218,454.20 as a result of reduced inventory levels at the end of the reporting period[17] - Accounts receivable dropped to CNY 2,625,490,208.92 from CNY 4,366,709,990.97, a decrease of about 40%[51] Research and Development - Research and development expenses increased by 30.40% to CNY 130,675,217.11, attributed to higher share-based payment expenses and R&D materials[42] - Research and development expenses increased to CNY 130,675,217.11 from CNY 100,214,402.29, marking a rise of approximately 30.3%[56] Shareholder Information - The company’s major shareholder, Ji Xuewen, holds 13.99% of the shares, with a total of 24,311,040 shares[9] Credit and Impairment - The company reported a significant increase in credit impairment losses, which rose by 1944.60% due to a decrease in accounts receivable[8] - Deferred tax assets increased by 60.34% to CNY 392,993,581.64 due to provisions for inventory impairment during the reporting period[17]

关于举办2022年度网上业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 证券代码：300769 证券简称：德方纳米 公告编号：2023-043 深圳市德方纳米科技股份有限公司 1、召开时间：2023年4月28日（星期五）下午15:00–17:00 2、召开地点：价值在线（www.ir-online.cn） 3、召开方式：网络互动方式 二、公司出席人员 公司董事长兼总经理孔令涌先生、财务总监林旭云女士、董事会秘书何艳艳 女士、独立董事毕晓婷女士、保荐代表人董瑞超先生。 深圳市德方纳米科技股份有限公司（以下简称"公司"）于2023年3月31日 在巨潮资讯网（http://www.cninfo.com.cn）上披露了《2022年年度报告》及《2022 年年度报告摘要》。为了便于广大投资者进一步了解公司2022年年度经营情况， 公司定于2023年4月28日（星期五）通过"价值在线"（www.ir-online.cn）举办 2022年度网上业绩说明会。现将具体情况公告如下： 一、本次业绩说明会召开的时间、地点和方式 三、投资者参与方式 投资者可于 20 ...

Financial Performance - The company's operating revenue for 2022 was ¥22,557,078,113.42, representing a 355.30% increase compared to ¥4,841,878,273.53 in 2021[12] - The net profit attributable to shareholders for 2022 was ¥2,380,198,555.42, up 188.36% from ¥800,592,881.91 in 2021[12] - The net cash flow from operating activities was -¥6,135,947,711.77, a decrease of 896.32% compared to -¥644,075,077.07 in 2021[12] - The total assets at the end of 2022 reached ¥29,094,244,309.19, a 224.20% increase from ¥8,949,202,121.57 in 2021[12] - The net assets attributable to shareholders at the end of 2022 were ¥8,813,064,394.06, reflecting a 185.45% increase from ¥3,062,598,795.67 in 2021[12] - In 2022, the company's total revenue reached approximately ¥22.56 billion, with a quarterly breakdown of ¥3.37 billion in Q1, ¥4.18 billion in Q2, ¥6.86 billion in Q3, and ¥8.14 billion in Q4[130] - The net profit attributable to shareholders for the year was approximately ¥2.38 billion, with quarterly figures of ¥761.71 million in Q1, ¥518.32 million in Q2, ¥547.65 million in Q3, and ¥552.52 million in Q4[130] - The net cash flow from operating activities was negative, totaling approximately -¥6.11 billion for the year, with quarterly values of -¥1.73 billion in Q1, -¥1.08 billion in Q2, -¥1.95 billion in Q3, and -¥1.38 billion in Q4[130] - The profit distribution plan includes a cash dividend of 10 RMB per 10 shares and a capital reserve increase of 6 shares for every 10 shares held[121] Market Trends and Growth - The company anticipates continued growth in the electric vehicle market, with a reported 96.9% increase in production and 93.4% increase in sales in 2022[18] - The lithium iron phosphate (LFP) battery market is expanding due to breakthroughs in battery technology and optimization of LFP cathode materials, enhancing energy density and safety, which are critical for commercial electric vehicles[57] - The proportion of lithium iron phosphate batteries in the electric vehicle battery market reached 62.36% in 2022, indicating a shift in demand dynamics[142] - The new energy storage market is projected to reach an installed capacity of over 30 million kilowatts by 2025, driven by national policies promoting carbon neutrality[60] - The market for energy storage is anticipated to reach a scale of over ¥100 billion by 2025, driven by government policies and market demand[140] - The Chinese government has implemented policies to support the development of the new energy vehicle (NEV) industry, aiming for NEV sales to account for approximately 20% of total new car sales by 2025[58] Research and Development - The company is focusing on the development of lithium iron phosphate batteries, which have a market share of over 90% in new energy storage projects[24] - The company established a standard, efficient, and continuous R&D system aimed at developing new products, improving product performance, and optimizing production processes[29] - The company has developed four core technologies for lithium-ion battery materials, including "self-heating evaporation liquid phase synthesis" and "ion doping technology"[105] - The core R&D team has extensive experience in lithium-ion battery materials, providing a competitive advantage in the industry[106] - The company has established several engineering research centers and laboratories focused on nano electrode materials and battery materials, enhancing its R&D capabilities[93] - The company aims to enhance its R&D capabilities through the establishment of a lithium power research institute and engineering technology center, focusing on innovation and talent development[146] - The company holds 338 patents, including 318 invention patents, with 98 patents granted, showcasing strong R&D capabilities[94] Production and Capacity - The company’s production capacity is bolstered by ongoing projects, including a new facility in Qujing with an annual capacity of 110,000 tons for new phosphate-based cathode materials[66] - The designed capacity for phosphate-based cathode materials is 204,122.49 tons, with a capacity utilization rate of 90.88%[89] - The company is constructing a new production base for 110,000 tons of new phosphate-based cathode materials, with an investment of 2,193,844,573.03 yuan, achieving 95.79% of the planned progress[186] - The company is also developing a project for 100,000 tons of nano lithium iron phosphate, with an investment of 1,249,146,444.99 yuan, reaching 99.67% of the planned progress[186] - The annual production capacity for the lithium iron phosphate project is 80,000 tons, with an investment of ¥1,120,670,854.09, currently at 62.43% completion[188] - The annual production capacity for the lithium supplement project is 20,000 tons, with an investment of ¥537,251,740.19, currently at 71.95% completion[188] Sales and Marketing - The company has shifted its sales model from purely selling products to offering "products + services," enhancing customer engagement and satisfaction[54] - The company’s marketing center is responsible for sales, technical support, and after-sales service, ensuring comprehensive customer service throughout the process[54] - The company has formed a strong brand influence in the lithium battery materials market, with downstream customers being well-known enterprises in the industry[54] - The company's top five customers accounted for 94.01% of total annual sales, with total sales amounting to ¥21,206,310,303.11[194] Financial Management - The company aims to balance supply assurance with efficient capital utilization through a well-structured procurement plan[29] - The company’s strategy includes leveraging ERP and OA systems to establish strict procurement management procedures[29] - Direct material costs increased by 1,379,740.25 thousand yuan, a 461.39% rise compared to the previous year, primarily due to soaring prices of key raw materials[173] - Cash inflow from investment activities surged by 841.92% year-on-year, mainly due to the maturity of financial products during the reporting period[179] - Cash inflow from financing activities increased by 492.22% year-on-year, attributed to the issuance of shares to specific investors and increased bank loans[180] Operational Challenges - In 2022, the domestic economy was impacted by multiple factors, leading to government policies aimed at promoting consumption, particularly in the automotive sector[45] - The net cash flow from operating activities decreased by 896.32% compared to the previous year, attributed to reduced discounting of notes receivable and increased operational expenditures related to new capacity[198] - R&D investment accounted for 1.92% of operating income, down from 3.31% in the previous year[196] Cost Management - Sales expenses increased by 41.31% to ¥45,189,965.11 due to higher share-based payment and sample costs[195] - Management expenses surged by 233.32% to ¥590,950,359.16, primarily due to increased salary expenses and share-based payments[195] - Financial expenses rose by 448.16% to ¥219,658,647.68, mainly due to increased interest expenses[195] - R&D expenses increased by 163.96% to ¥432,362,468.12, driven by higher personnel costs and material expenses[195]